![](/images/2013/post-sep.jpg)
Non-Small Cell Lung Cancer (NSCLC) Market Segments, Drivers, Restraints, And Trends For 2024-2033
The Business Research Company's Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
LANDON, GREATER LANDON, UK, August 2, 2024 /EINPresswire.com/ -- The non-small cell lung cancer (NSCLC) market has experienced robust growth in recent years, expanding from $18.02 billion in 2023 to $20.1 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to evolution of immunotherapy, genomic profiling and precision medicine, expansion of clinical trials, smoking cessation initiatives.
Strong Future Growth Anticipated
The non-small cell lung cancer (NSCLC) market is projected to continue its strong growth, reaching $29.95 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to emerging combination therapies, integration of artificial intelligence (AI), expansion of personalized vaccines, global collaborations in research, patient-centric care.
Explore Comprehensive Insights Into The Global Non-Small Cell Lung Cancer (NSCLC) Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13232&type=smp
Growth Driver Of The Non-Small Cell Lung Cancer (NSCLC) Market
The increasing rate of tobacco consumption is expected to propel the growth of the non-small cell lung cancer (NSCLC) market going forward. Tobacco consumption refers to the use of tobacco products by individuals, typically in the form of smoking, chewing, or snuffing, which introduces nicotine and other chemicals into the body. Tobacco smoke contains several carcinogens that can damage the DNA (deoxyribonucleic acid) in lung cells, leading to mutations and the uncontrolled growth of cancerous cells, including non-small-cell lung cancer (NSCLC).
Order Your Report Now For Swift Delivery:
https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report
Major Players And Market Trends
Key players in the non-small cell lung cancer (NSCLC) market include Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company.
Major Companies operating in the non-small cell lung cancer (NSCLC) market are focused on developing multiple treatment options, such as monotherapy treatments, to gain a competitive edge. Monotherapy treatment is the use of a single drug or therapy to treat a medical disorder or condition, and it involves utilizing a single method or treatment approach rather than a combination of multiple interventions.
Segments:
1) By Type: Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types
2) By Therapy: Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Other Therapies
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Other Distribution Channels
Geographical Insights: North America Leading The Market
North America was the largest region in the non-small cell lung cancer (NSCLC) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-small cell lung cancer (NSCLC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Non-Small Cell Lung Cancer (NSCLC) Market Definition
Non-small cell lung cancer (NSCLC) is a type of epithelial lung cancer that develops in the tissues of the lungs and is characterized by the abnormal growth of cells. It is primarily caused by long-term smoking, genetic mutations, air pollution, and secondhand smoke.
Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on non-small cell lung cancer (NSCLC) market size, non-small cell lung cancer (NSCLC) market drivers and trends, non-small cell lung cancer (NSCLC) market major players, non-small cell lung cancer (NSCLC) competitors' revenues, non-small cell lung cancer (NSCLC) market positioning, and non-small cell lung cancer (NSCLC) market growth across geographies. The non-small cell lung cancer (NSCLC) market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Small Cell Lung Cancer Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/small-cell-lung-cancer-therapeutics-global-market-report
Urinary Tract Cancer Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/urinary-tract-cancer-global-market-report
Blockchain Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blockchain-services-global-market-report
About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
![](https://lungcancer.einnews.com/tracking/article.gif?aid=732421490§ion=einpresswire&a=YsfMbI44UwJ34R-K&i=h3UZBzE-s40NgMx_)
Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry, International Organizations, Technology, World & Regional
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release